CVRx board responds to shareholder letter on valuation concerns

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. NDAQ
7. QGEN
8. CSX
9. LRCX
10. BFH

Go back to CVRx board responds to shareholder letter on valuation concerns

CVRx Responds to Letter from Pointillist Family Office

August 25, 2026 8:00 AM EDT

MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today issued the following statement in response to the public letter to CVRxs Board of Directors from Jorey Chernett at Pointillist Family Office, dated August 24, 2026:

The Board of Directors and leadership team are committed to acting in the best interests of all CVRx shareholders and regularly evaluate a full range of options to maximize value for all shareholders. The Board... More